A self-assembling hydrophobically modified chitosan capable of reversible hemostatic actionMatthew B. Dowling, Srinivasa R. Raghavan, Rakesh Kumar et al.|Biomaterials|2011Cited by 241
The use of low‐titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhageSusan M. Shea, Philip C. Spinella, Amanda M. Staudt et al.|Transfusion|2020Cited by 124
Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhageSusan M. Shea, Philip C. Spinella, Emily Mihalko et al.|Journal of Thrombosis and Haemostasis|2023Cited by 42
The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center TrialPhilip C. Spinella, Isaiah R. Turnbull, Anja Fuchs et al.|Frontiers in Immunology|2020Cited by 42
The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double‐blind, placebo‐controlled, single‐center trialPhilip C. Spinella, Grant V. Bochicchio, Kelly Bochicchio et al.|Transfusion|2022Cited by 27